Get the Stockscreener App
13.31
2.86%
0.37
After Hours:
13.28
-0.03
-0.23%
Uipath Inc stock is traded at $13.31, with a volume of 47.35M.
It is up +2.86% in the last 24 hours and up +12.61% over the past month.
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
See More
Previous Close:
$12.94
Open:
$14.86
24h Volume:
47.35M
Relative Volume:
3.56
Market Cap:
$6.09B
Revenue:
$1.41B
Net Income/Loss:
$-91.57M
P/E Ratio:
-83.19
EPS:
-0.16
Net Cash Flow:
$308.77M
1W Performance:
+7.60%
1M Performance:
+12.61%
6M Performance:
-6.33%
1Y Performance:
+10.27%
1-Day Range:
$12.91
$14.98
1-Week Range:
$12.46
$14.98
52-Week Range:
$9.38
$15.93
Uipath Inc Stock (PATH) Company Profile
Name
Uipath Inc
Sector
Industry
Phone
(844) 432-0455
Address
ONE VANDERBILT AVENUE, NEW YORK
Compare PATH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PATH
Uipath Inc
|
13.31 | 6.62B | 1.41B | -91.57M | 308.77M | -0.16 |
|
MSFT
Microsoft Corporation
|
460.36 | 3.35T | 270.01B | 96.64B | 69.37B | 12.94 |
|
ORCL
Oracle Corp
|
165.53 | 437.38B | 55.78B | 12.16B | 5.81B | 4.26 |
|
PLTR
Palantir Technologies Inc
|
131.78 | 291.00B | 3.12B | 570.69M | 1.32B | 0.23 |
|
CRWD
Crowdstrike Holdings Inc
|
471.37 | 113.48B | 3.95B | -19.27M | 1.07B | -0.08 |
|
FTNT
Fortinet Inc
|
101.78 | 78.96B | 6.14B | 1.88B | 2.07B | 2.43 |
Uipath Inc Stock (PATH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-13-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-24 | Initiated | UBS | Sell |
| Jun-03-24 | Downgrade | Macquarie | Outperform → Neutral |
| May-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-30-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-24 | Downgrade | Truist | Buy → Hold |
| May-30-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-08-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Mar-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-14-24 | Reiterated | Needham | Buy |
| Feb-21-24 | Initiated | Scotiabank | Sector Perform |
| Jan-02-24 | Initiated | William Blair | Outperform |
| Jun-09-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-21-23 | Initiated | DA Davidson | Neutral |
| Mar-16-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-03-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-18-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Sep-07-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-22 | Downgrade | Mizuho | Buy → Neutral |
| Sep-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Resumed | Canaccord Genuity | Buy |
| Jan-25-22 | Upgrade | Macquarie | Neutral → Outperform |
| Jan-20-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-09-21 | Upgrade | Berenberg | Hold → Buy |
| Dec-03-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-16-21 | Initiated | Credit Suisse | Outperform |
| Sep-17-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Jul-12-21 | Initiated | Summit Insights | Sell |
| May-17-21 | Initiated | BMO Capital Markets | Market Perform |
| May-17-21 | Initiated | Barclays | Equal Weight |
| May-17-21 | Initiated | BofA Securities | Buy |
| May-17-21 | Initiated | Canaccord Genuity | Hold |
| May-17-21 | Initiated | Cowen | Outperform |
| May-17-21 | Initiated | DA Davidson | Buy |
| May-17-21 | Initiated | Evercore ISI | In-line |
| May-17-21 | Initiated | JP Morgan | Neutral |
| May-17-21 | Initiated | KeyBanc Capital Markets | Overweight |
| May-17-21 | Initiated | Macquarie | Neutral |
| May-17-21 | Initiated | Mizuho | Buy |
| May-17-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-17-21 | Initiated | Needham | Buy |
| May-17-21 | Initiated | Oppenheimer | Perform |
| May-17-21 | Initiated | RBC Capital Mkts | Sector Perform |
| May-17-21 | Initiated | Truist | Buy |
| May-17-21 | Initiated | Wells Fargo | Equal Weight |
| May-17-21 | Initiated | Wolfe Research | Peer Perform |
| May-13-21 | Initiated | Berenberg | Hold |
View All
Uipath Inc Stock (PATH) Latest News
GTS Securities LLC Sells 276,642 Shares of UiPath Inc. (NYSE:PATH) - MarketBeat
Bank of America Corp DE Reduces Stake in UiPath Inc. (NYSE:PATH) - MarketBeat
UiPath (NYSE:PATH) Stock Price Expected to Rise, Evercore ISI Analyst Says - MarketBeat
UiPath (NYSE:PATH) Stock Price Expected to Rise, BMO Capital Markets Analyst Says - MarketBeat
Mackenzie Financial Corp Reduces Position in UiPath Inc. (NYSE:PATH) - MarketBeat
Barclays Forecasts Strong Price Appreciation for UiPath (NYSE:PATH) Stock - MarketBeat
UiPath (NYSE:PATH) Price Target Raised to $13.00 - MarketBeat
UiPath (NYSE:PATH) Price Target Raised to $13.00 at Scotiabank - MarketBeat
UiPath (NYSE:PATH) Given New $14.00 Price Target at DA Davidson - MarketBeat
Royal Bank of Canada Forecasts Strong Price Appreciation for UiPath (NYSE:PATH) Stock - MarketBeat
UiPath (NYSE:PATH) Shares Gap Up After Earnings Beat - MarketBeat
UiPath (NYSE:PATH) Price Target Raised to $12.00 at Wells Fargo & Company - MarketBeat
UiPath price target raised to $15 from $12 at TD Cowen - Yahoo Finance
UiPath price target raised to $15 from $11 at Evercore ISI - Yahoo Finance
UiPath (NYSE:PATH) Earns "Hold" Rating from Needham & Company LLC - MarketBeat
UiPath (NYSE:PATH) Price Target Raised to $14.00 at Barclays - Defense World
UiPath (NYSE:PATH) Given New $15.50 Price Target at BMO Capital Markets - Defense World
UiPath (NYSE:PATH) Given New $15.00 Price Target at Royal Bank of Canada - Defense World
UiPath’s (PATH) Hold Rating Reaffirmed at Needham & Company LLC - Defense World
Uipath Inc.’s Restructuring: Navigating Risks and Potential Pitfalls - TipRanks
UiPath (NYSE:PATH) Shares Gap Up After Better-Than-Expected Earnings - Defense World
UiPath (PATH) Price Target Lifted to $15 Following Strong Q1 Metrics - TradingView
UiPath (PATH) Stock Rating Maintained as Hold by Analyst | PATH - GuruFocus
Opportunities in Agentic Automation - marketscreener.com
UiPath (NYSE:PATH) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
UiPath (PATH) Price Target Increased by BMO Capital | PATH Stock News - GuruFocus
UiPath (PATH) Stock Rises Over 8% After Market Surge | PATH Stoc - GuruFocus
TD Cowen Increases Price Target for UiPath (PATH) After Strong P - GuruFocus
UiPath (PATH) Price Target Raised by RBC Capital Following Stable Quarter | PATH Stock News - GuruFocus
UiPath (PATH) Target Price Raised by Evercore ISI Amid Positive Q1 Results | PATH Stock News - GuruFocus
BofA raises UiPath stock price target to $12, keeps underperform By Investing.com - Investing.com Canada
Analysts Applaud UiPath's AI Traction, But Net New ARR Slide Sparks Caution - Benzinga
UiPath (PATH) Shares Surge as Revenue Outlook Exceeds Expectatio - GuruFocus
UiPath (NYSE:PATH) Announces Q1 Results With US$357 Million Revenue and Updated Guidance - simplywall.st
BofA raises UiPath stock price target to $12, keeps underperform - Investing.com
These Analysts Boost Their Forecasts On UiPath After Upbeat Q1 Results - Benzinga
UiPath CEO Dines Says Company ‘Survival’ Hinges On AI Success - CRN Magazine
Why Is UiPath (PATH) Stock Rocketing Higher Today - FinancialContent
Elastic And PagerDuty Struggle As UiPath Sees A Small Rise - Finimize
UiPath stock target raised to $15.50 at BMO Capital By Investing.com - Investing.com Nigeria
Unity upgrade, UiPath earnings, Regeneron drug trial results - Yahoo Finance
Elastic, PagerDuty, UiPath Face Growth, Revenue Hurdles, Morgan Stanley Says - marketscreener.com
TD Cowen raises UiPath stock price target to $15 from $12 - Investing.com Australia
UiPath Tops Q1, Raises FY26 Guidance - TradingView
UiPath stock price target raised to $15 at RBC Capital - Investing.com
UiPath (PATH) Receives Analyst Price Target Increase | PATH Stock News - GuruFocus
UiPath stock price target raised to $15 at RBC Capital By Investing.com - Investing.com India
UiPath (PATH) Stock Rises Over 8% After Market Surge | PATH Stock News - GuruFocus
Scotiabank Ups UiPath (PATH) Price Target Despite Cautious Outlo - GuruFocus
Scotiabank Ups UiPath (PATH) Price Target Despite Cautious Outlook | PATH Stock News - GuruFocus
UiPath Stock Rises After Earnings, Guidance Hike. Why Wall Street Is More Cautious. - Barron's
Uipath Inc Stock (PATH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
5.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):